Adastra Holdings Ltd.
Adastra Holdings Ltd. is a Canadian company specializing in the extraction and processing of cannabis products for both recreational and medical markets. Renowned for producing two leading Canadian concentrates brands, the company emphasizes product innovation and commercialization tailored to adult-use and medical cannabis sectors. Its operations include cannabis analytical testing and processing solutions, positioning Adastra as a significant player in the Canadian cannabis industry. The company has navigated recent corporate restructurings and focuses on developing high-quality cannabis concentrates that serve evolving consumer needs within the legal cannabis market.
€0.08
+€0.00 (+0.00%)
EOD Oct 16, 2026
The business is unprofitable at the operating level (-3.91% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 11.8% YoY with margins expanding 4.2pp. However, free cash flow softened 65%, worth monitoring whether this is timing or structural.
Free cash flow declined 65% versus the prior year, cash generation momentum has weakened. Net debt of C$2M represents 5.7x FCF, leverage limits flexibility.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
C$17M
▲ +11.8% YoY
Net Income (TTM)
-C$14M
▼ -273.4% YoY
Op. Margin
-14.42%
▲ +4.2pp YoY
ROIC
-6.56%
▲ +0.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-C$324K
▼ -65.3% YoY
Op. Cash Flow (TTM)
-C$207K
▼ -55.6% YoY
Net Debt
C$2M
Cash & Equiv.
C$1M
3Y CAGR: +64.0%
Continue Research
Is Adastra Holdings (XTXXF) overvalued?
Adastra Holdings (XTXXF)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Adastra Holdings scores 40/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from company filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
Is Adastra Holdings a high-quality business?+
Adastra Holdings scores 40 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a -14.4% operating margin and a -6.6% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from company filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Is Adastra Holdings a good stock to buy right now?+
That depends on valuation and quality together, not either alone. you should weigh XTXXF's valuation and scores 40/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from company filings, not investment advice.
Related stocks: Drug Manufacturers - Specialty & Generic
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.